A patent infringement suit filed by Merck & Co. Inc. against Teva Parenteral Medicines, Inc. relating to Cancidas is ongoing, Merck disclosed in its August 8, 2011, Form 10-Q filing…
A patent infringement suit filed by Merck & Co. Inc. against Apotex Corp. relating to Nasonex is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing with the…
A patent infringement suit filed by Merck & Co. Inc. against Hamni USA, Inc. relating to Nexium is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing with…
A patent infringement suit filed by Merck & Co. Inc. against Sandoz Inc. relating to AzaSite is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing with the…
A patent infringement suit filed by Merck & Co. Inc. against Teva Parenteral Medicines, Inc. relating to Integrilin is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing…
Merck & Co. Inc. continues to cooperate with the Federal Trade Commission after it received a Civil Investigative Demand regarding a patent settlement agreement it entered with Ranbaxy Laboratories Ltd.,…
Patent infringement actions filed by Pfizer Inc. against Teva Pharmaceutical Industries and Actavis, Inc. relating to Neurontin (gabapentin) were settled in May 2011.
Several years ago the Company filed patent-infringement actions…
Patent infringement actions filed by Pfizer Inc. against Teva USA and Impax Laboratories, Inc. relating to Detrol LA (tolterodine) are ongoing.
In October 2007 and January 2008, respectively, Teva USA and…
Patent infringement actions filed by King Pharmaceuticals, Inc. Against Teva Pharmaceutical Industries and Intelliject, Inc. relating to EpiPen are ongoing.
King brought patent-infringement actions against Sandoz in the U.S District Court…
Patent infringement actions filed by Pfizer Inc. against Sandoz and Mylan Pharmaceuticals Inc. relating to Detrol LA (tolterodine) are ongoing.
In March 2008 and May 2010, respectively, Sandoz and Mylan notified…